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Abstract 
 
The interaction of oxidovanadium(V) with INHOVA (the condensation product of isoniazid 
and o-vanillin) lead to the formation of the ester-like complex [VO(INHOVA) 
EtO(OH2)]Cl·H2O (1). Crystals suitable for X-ray diffraction methods were obtained. The 
complex crystallizes as a dimer in the space group P21/c of the monoclinic system. A 
detailed analysis, including solid-state vibrational spectroscopy and electronic 
spectroscopy in DMSO solution, was performed for both INHOVA and complex (1). A 
complete theoretical study based on DFT was also carried out. The calculations were of 
valuable assistance in the spectra assignments and interpretation. The electrochemical 
characterization allows determining the redox behavior of INHOVA and complex (1). 
Cytotoxicity was assayed against the chronic myelogenous leukemia K562 cell line. The 
IC50 values obtained denote that both the ligand and complex (1) are good candidates for 
further studies. 
 
Keywords: oxidovanadium(V), isoniazid, o-vanillin, structural study, DFT calculations, 
cytotoxicity. 
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1. Introduction 
Condensation reaction of the antituberculosis agent isoniazid (isonicotinic acid hydrazide, 
INH) [1] with o-vanillin (2-hydroxy-3-meyhoxybenzaldehyde, o-HVa) leads to the formation 
of a stable and active hydrazone, N'-[(1E)-(2-hydroxy-3-
methoxyphenyl)methylene]isonicotinohydrazide, INHOVA (see Scheme 1). It is an 
interesting member of the family of Schiff bases containing aromatic rings with a OH group 
in ortho position to the imino moiety. This kind of compounds are of relevance mainly due 
to the existence of either O–H···N or O···H–N hydrogen bonds and the tautomerism 
between enol-imine and keto-amine forms. Moreover, some hydrazones of INH with 
hydroxyaldehydes have shown conserved activity and less toxicity upon inactivation of the 
NH2 group of the parent hydrazide [2]. In particular, a group of hydrazones were found to 
be even more effective than INH itself as antituberculosis agents [3,4]. 
 
 
 
 
 
Scheme 1. INHOVA 
 
INHOVA has been previously obtained and its crystal structure has been determined [5-7]. 
Moreover, a detailed structural, spectroscopic and theoretical study has been reported by 
our group [8]. 
In the field of coordination chemistry, this type of hydrazones has received special 
attention as polyfunctional ligands in metal complexes, including vanadium centers [9,10]. 
This kind of hydrazones and their metal complexes exhibit a variety of biological and 
pharmaceutical activities, being recognized as antimicrobial, antituberculosis, antitumoral 
and antioxidant agents [11-13]. Cytotoxicity assays of some organotin(IV) complexes 
containing INHOVA in a series of human cancer cell lines placed them as promising 
anticancer agents [14]. 
In addition to the widely known therapeutic properties of oxidovanadium(V) compounds, 
such as their insulin-mimetic activity, there is a growing interest in vanadium compounds 
as potential therapeutic agents for the treatment of cancer [15-17]. A complex of this metal 
with an o-HVa-derived Schiff base ligand has been determined to bind to CT-DNA in a non-
classical intercalative mode and to possess a strong affinity with the BSA protein, inducing 
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conformational changes [18]. Among the immense variety of oxidovanadium(V) 
complexes, some examples of ester-like coordination compounds containing organic 
ligands, including hydrazones, have been reported [19-23]. The structure of a complex 
containing this metal as the VO2 center coordinated to a ligand closely related to INHOVA 
has been described but only briefly discussed [24]. 
In this work, the interaction of oxidovanadium(V) with INHOVA was studied in an attempt to 
obtain metal complexes of therapeutic interest. The complex [VO(INHOVA) 
EtO(OH2)]Cl·H2O (1, Scheme 2) was prepared from ethanolic solutions of the reactants 
and obtained as crystals suitable for X-ray structure determination. As a consequence of 
the protonation of the pyridinic nitrogen, the INHOVA ligand appears as a monoanion. An 
extensive characterization, including vibrational spectroscopy of the solid, and electronic 
spectroscopy and electrochemical analysis in solution, was performed. A complete 
theoretical study based on DFT was also carried out. The calculations were of valuable 
assistance in the spectra assignments and interpretation. Cytotoxicity on K562 cells was 
evaluated for both INHOVA and complex (1), with promising results. 
 
 
 
 
 
 
 
 
Scheme 2. The complex cation [VO(INHOVA) EtO(OH2)]+ 
 
2. Experimental 
 
2.1. Syntheses  
INH and o-HVA were acquired from Sigma-Aldrich, HCl and VOCl2 (50% aqueous 
hydrochloric solution) from Carlo Erba and EtOH from Biopack, all of them of analytical 
grade, were used as purchased. 
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2.1.1 Synthesis of the ligand. 
The hydrazone was prepared according to the procedure previously reported [8]. Even 
when it was obtained as a chloride of the pyridinium salt (INHOVAH+Cl-), it will be referred 
as INHOVA, as it has been named in previous publications. 
 
2.1.2. Synthesis of the complex (1). 
0.2 mmol of INHOVA (0,0633 g) were dissolved in 30 mL of EtOH under heating and 
stirring. The resulting solution was dropwise added to a mixture of 0.2 mmol of VOCl2 (110 
µL) with 10 mL of EtOH, while stirring, leading to an amber-colored solution. The system 
was then refluxed during 3 hours turning to a darker colour. After standing at room 
temperature for a couple of weeks, a crystalline solid was observed. The caramel-colored 
crystals were filtered off, washed with cold EtOH and dried in a desiccator. 
 
2.2- X-ray diffraction data 
Single crystal X-ray diffraction experiment was performed in a Bruker-Nonius Kappa-CCD 
diffractometer at room temperature using MoKα radiation. The structure was solved by 
direct methods using SHELXS and refined by full-matrix least-squares on F2 using 
SHELXL-97. All non-hydrogen atoms were refined using anisotropic displacement 
parameters. The hydrogen atoms were generated in idealized geometries, and they were 
refined according to the riding model. The carbon atoms C12e and C22e, belonging to the 
ethoxo ligand, were described disordered with occupation of 39% and 61%, respectively. 
 
2.3- Spectroscopic analysis 
The FTIR spectra were obtained with a Bruker EQUINOX 55 spectrometer in KBr discs 
with 4 cm-1 resolution and 60 scans, in the 4000-400 cm-1 range. The electronic absorption 
spectra were measured in DMSO and EtOH (1 x 10-5 M) in the 200-800 nm spectral range. 
They were recorded with a Hewlett-Packard 8452-A diode array spectrometer using 10 
mm quartz cells. 
 
2.4. Computational methods 
The X-ray structure of the complex cation present in (1) was taken as the starting 
geometry for optimization. The geometry optimization was conducted in vacuum and was 
performed with the GGA B97-D exchange-correlation functional that includes long-range 
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dispersion corrections [25]. The 6-311G(d,p) basis set was used for H, C, N and O, 
whereas the LANL2TZ pseudopotential was employed for V. After optimization, the 
Hessian matrix of the total electronic energy with respect to the nuclear coordinates was 
constructed and diagonalized to check whether the optimized structure is a local minimum 
on the potential energy surface of the complex. The eigenvalues of the hessian matrix 
were then converted to harmonic vibrational frequencies that can be compared with 
experimental frequencies. 
Vertical electronic transitions were calculated with the one-parameter hybrid GGA PBE0 
exchange-correlation functional [26] using the geometry optimized with the B97-D 
functional. In this case, diffuse functions were added to the 6-311G(d,p) basis set for N and 
O. The IEF-PCM method [27] was used to include implicitly solvent effects (DMSO and 
EtOH) in the calculation of the electronic transitions. All the calculations were performed 
with the Gaussian 09 program [28]. 
 
2.5. Electrochemical characterization 
The redox behavior of INHOVA and complex (1) was determined by cyclic voltammetry in 
DMSO and EtOH solutions using a computer controlled potenciostat/galvanostat PAR 
model 263A. Tetrabutylammonium hexafluorophosphate (TBAPF6) was employed as 
supporting electrolyte (Fluka , electrochemical grade). 
Measurements were performed on a glassy carbon disc electrode in absence of O2 at 
different scan rates (v). A continuous gas stream was passed over the solution during the 
measurements A platinum wire was used as counter electrode, whereas Ag/(10-3M) 
AgNO3, in CH3CN /10-1 M (TBA)PF6, was employed as reference electrode. This electrode 
was calibrated against the [Fe(C5H5)2]/[Fe(C5H5)2]+ redox couple, for which a potential of 
+0.17V was determined. 
 
2.6. Cytotoxicity assays 
The ligand and the metal complex were tested against the chronic myelogenous leukemia 
K562 cell line, purchased from the Rio de Janeiro Cell Bank (number CR083 of the RJCB 
collection). It was established from the pleural effusion of a 53 year old female with chronic 
myelogenous leukemia in terminal blast crisis. Cells were cultured in RPMI 1640 medium 
supplemented with 10% fetal calf serum (CULTLAB, São Paulo, Brazil) at 37 °C in a 
humidified 5% CO2 atmosphere. Cultures grow exponentially from 105 cells mL-1 to about 
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106 cells mL-1 in 3 days. Cell viability was checked by Trypan Blue exclusion. Cell number 
was determined by Coulter counter analysis. 
For cytotoxicity assessment, 1 × 105 cell mL-1 were cultured for 72 h in the absence and 
the presence of various concentrations of the compounds. The sensitivity to INHOVA and 
its oxidovanadium(V) complex was evaluated by the concentration needed to inhibit cell 
growth by 50%, the IC50. Stock solutions of the compounds were prepared in DMSO. The 
final concentration of DMSO in the experiments with cells was below 0.5% and we have 
checked that the solvent has no effect on cell growth at this concentration. 
 
3. Results and discussion 
 
3.1. Crystal Structure 
The solid crystalized as a chloride salt of the cationic complex, in the monoclinic system, 
space group P21/c. Crystal data and structure refinement results are summarized in Table 
1. The ligand acts in a tridentate manner through the O,N,O-donor system constituted by 
the deprotonated phenol O4, the N1 atom of the hydrazonic linkage and the enolate 
oxygen O3. It appears as a monoanion (INHOVA-) as a consequence of the protonation of 
the pyridinic nitrogen. The distorted octahedral coordination environment is completed by 
an oxo ligand, a disordered solvent-derived ethoxide anion and a water molecule. An 
ORTEP drawing is shown in Figure 1. 
The crystalline packing (Figure 2) shows that complex cations aggregate into a dimer [R22 
(10)] by means of moderate intermolecular H-bonds involving the coordinated water 
molecule and the nitrogen atom N2 [O1W···N2 =2.907(3) Å]. The interaction of complex 
cations with chloride counter-ions and crystallization water molecules stabilizes the bilayer 
overall arrangement along the (-100) plane. Corresponding intra-molecular bond distances 
and angles can be obtained directly from the available .cif file. 
 
 
 
 
 
 
  
7 
 
Table 1. Crystal data and structure refinement results for complex (1). 
 
Empirical formula C16H21N3O7VCl 
Formula weight 453.76 
Temperature/K 293(2) 
Crystal system Monoclinic 
Space group P21/c 
a/Å 8.7126(17) 
b/Å 23.170(5) 
c/Å 9.945(2) 
α/° 90 
β/° 100.97(3) 
γ/° 90 
Volume/Å3 1970.8(7) 
Z 4 
ρcalcg/cm3 1.5292 
µ/mm-1 0.682 
F(000) 938.3 
Crystal size/mm3 0.21 × 0.08 × 0.02 
Radiation Mo Kα (λ = 0.71073) 
2Θ range for data collection/° 6.7 to 50.7 
Index ranges −10 ≤ h ≤ 11, −29 ≤ k ≤ 30, −12 ≤ l ≤ 12 
Reflections collected 23755 
Independent reflections 3579 [Rint = 0.0456, Rsigma = 0.0472] 
Data/restraints/parameters 3579/6/256 
Goodness-of-fit on F2 1.069 
Final R indexes [I>=2σ (I)] R1 = 0.0379, wR2 = 0.0856 
Final R indexes [all data] R1 = 0.0612, wR2 = 0.0975 
Largest diff. peak/hole / e Å-3 0.37/−0.36 
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Figure 1. ORTEP representation (50% probability ellipsoids) of complex (1). H-atoms in 
the disordered ethoxide ligand are omitted for clarity. 
 
 
 
Figure 2. Dimer in the crystalline packing of complex (1) (disordered atoms, the 
crystallization water molecules and chloride counter-ions are omitted for the sake of clarity) 
 
3.2. Geometry optimization and comparison with experimental results 
Selected geometrical parameters obtained after geometry optimization are listed in Table 
2. Experimental information is also shown in that table. The optimized parameters agree 
very well in general with experimental data. The V-O1w bond distance is predicted to be 
more than 0.3 Å larger than the experimental value, see Figure 1 for labels. It is argued 
that this is due to the fact that the water molecule is stabilized at a shorter V-O distance by 
intermolecular H-bonds as it is shown in Figure 2 for the packing in the solid state. 
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Intermolecular interactions are obviously absent in the calculation carried out for the 
isolated complex, thus water molecules bound to the V ion through H-bonds could be able 
to stabilize at larger distances. On the other hand, the other V-O bond distances show a 
very good agreement with experimental data, with an average error of only 0.013 Å. The V-
N bond distance agrees also very well with the experimental value, being only 0.024 Å 
larger. Those findings reinforce the argument given above in the sense that the V-O and V-
N bond distances are well reproduced when neither the O atoms or the N atoms are 
involved in intermolecular H-bonds. Maximum errors in bond angles are about 8 degrees 
and involve the oxygen atom of the water molecule, namely, α(O4-V-O1w), α(O2-V-O1w) 
and α(N1-V-O1w). Dihedral angles are very well described by the calculated parameters. 
The largest error is observed in τ(O4-V-O3-C), for which a deviation of 20 degrees from 
experimental values is found. The calculations seem to suggest that the environment of 
the V(V) ion is almost unaltered when the solid is formed, with the exception of the water 
molecule, which is further stabilized at a shorter distance of the metallic ion by neighbor 
molecules, thus completing its coordination sphere. 
 
Table 2. Experimental and calculated geometric parameters. Distances (d) are in Å and 
bond and dihedral angles (α and τ, respectively) are in degrees. See Figure 1 for labels. 
 
 Exp. Calc.  Exp. Calc. 
d(V-O2) 1.577 (2) 1.591 α(O2-V-O1w) 177.32 (10) 170.1 
d(V-O1e) 1.769 (2) 1.776 α(O1e-V-O1w) 79.34 (9) 83.1 
d(V-O4) 1.859 (2) 1.883 α(O4-V-O1w) 82.17 (9) 73.0 
d(V-O3) 1.984 (2) 1.992 α(O3-V-O1w) 79.59 (9) 77.2 
d(V-N1) 2.116 (2) 2.140 α(N1-V-O1w) 84.20 (9) 76.3 
d(V-O1w) 2.323 (2) 2.695 τ(O2-V-O4-C) 50.6 (3) 53.6 
α(O2-V-O1e) 101.64 (12) 106.6 τ(O1e-V-O4-C) 155.5 (2) 164.0 
α(O2-V-O4) 99.94 (11) 102.6 τ(O3-V-O4-C) 
−78.2 (3) −86.8 
α(O1e-V-O4) 104.71 (10) 102.4 τ(N1-V-O4-C) 
−42.7 (2) −39.5 
α(O2-V-O3) 97.84 (11) 104.0 τ(O1w-V-O4-C) 
−127.7 (3) −117.3 
α(O1e-V-O3) 92.52 (9) 90.2 τ(O2-V-O4-C) 
−93.6 (2) -84.1 
α(O4-V-O3) 152.06 (9) 145.8 τ(O1e-V-O3-C) 164.3 (2) 168.7 
α(O3-V-N1) 94.36 (11) 94.5 τ(O4-V-O3-C) 35.6 (3) 56.0 
α(O1e-V-N1) 160.37 (10) 156.2 τ(N1-V-O3-C) 
−1.3 (2) 6.6 
α(O4-V-N1) 83.36 (9) 83.1 τ(O1w-V-O3-C) 85.6 (2) 85.8 
α(O3-V-N1) 73.92 (9) 73.8    
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3.3. Infrared spectroscopy 
The IR spectrum was analyzed in comparison with that corresponding to the free ligand 
(INHOVA). Experimental and calculated values of the selected spectral signals are 
depicted in Table 3, together with the respective assignments, done with the help of 
theoretical results. A complete list of frequencies and respective assignments are provided 
as Supplementary Material (Table S1). Figure 3 shows the registered spectra in the more 
relevant region. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. IR spectra in the 1800-400 cm-1 spectral region. Ligand (dotted line, top), and 
complex (solid line, bottom)  
 
Table 3. Selected experimental and calculated IR data (4000-400 cm-1) of complex (1) and 
INHOVA. Reported frequencies are in cm-1. 
 
INHOVA Calc(a) Complex (1) Calc. Assignment 
  3366 s 3828 νas(H2O)coord. 
  3272 s 3718 νs(H2O)coord. 
3157 w 3492   νNH(hydrazone) 
3014 w 3594   νOH 
  2932 w 3058 
3043 
νasCH3(ethoxo) 
  2905 sh 2956 νsCH3(ethoxo) 
  2804 vw 2898 νsCH2(ethoxo) 
2590m,b 3513 2650 w,b 3529 νN3H 
1688 vs 1795   νC=O 
1606 vs 1689   νC=N  
   1611 δ(H2O)cord. 
  1609 s 1565 νC=N1 + νC=N2 
  1444 s 1450 νO3-C=N2 + δCH(INH) 
1374 m 1338   δOH 
  1365 s 1409 νC-O4(V) + ν(coord ring o-HVA) (see text)  
   1379 ν(coord ring o-HVA) (see text) 
  1270 m 1333 ρwCH2 
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1256 vs 1263 1259 vs  1265 νAr-OCH3 + δCH(o-HVA) 
  1228 m 1234 νC-O4(V) + δCH(all) + δN3H 
  987 s 1036 νV=O2 + νas (C-C-O1e) 
893 m 612   γOH 
  593 w 593 νN1-V 
  566 w 565 νV-O4 + γring(o-HVA)  
  496 w 556 νV-O3 
(a) Data from ref. [8]. 
 
Calculations show a strong coupling of several modes. The assignments were done taking 
into account predominant vibrations at each frequency. Regarding the present results, the 
previously reported assignment of the ligand spectrum [8] has been revised. Some 
differences were found that can be attributed, at least in part, to the change in the 
functional employed in the DFT calculations, used to help in the assignments. 
Characteristic stretching bands of coordinated water are present in the complex spectrum, 
whereas the one expected for the bending mode of this molecule (calculated value: 1611 
cm-1) should be overlapped with the strong band at 1609 cm-1. This band is related to the 
out of phase C=N stretchings in the –C=N1-N2=C- moiety, characteristic of enolate 
coordination of hydrazones. in accordance with the crystallographic results. 
The INHOVA spectrum shows a broad intense band at 2590 cm-1 assigned to the pyridinic 
N-H stretching according to the data reported for this mode in related compounds [29]. The 
complex spectrum shows a poorly resolved broad band centered at approximately 2650 
cm-1 which can be attributed to this vibration. The discrepancies between experimental and 
calculated frequencies are expected since vibrations including atoms involved in H-bonds 
are always overestimated. In this case, N3-H interacts with one of the lone electron pairs 
of a crystallization water molecule. 
The bands assigned to C-H stretching modes of the ethoxo group appear between 2932 
and 2804 cm-1 in the spectrum of the complex. 
Bands assigned to modes involving phenolic OH and hydrazone NH groups in the ligand 
are absent after coordination to the metal. Moreover, the strong band attributed to C=O3 
stretching in INHOVA disappears in the spectrum of (1). Calculations indicate that the new 
band at 1444 cm-1 in the spectrum of (1) can be attributed to the stretching of O3-C=N2 
linkage, involving the coordinated atoms of the INH fragment. Additionally, the band at 
1365 cm-1 in the spectrum of the complex is assigned to the νC-O4(V) mode coupled with 
the stretchings involving C1-C6-C7-N1atoms of INHOVA (coordination ring o-HVA). These 
results are in accordance with the ONO donor system of the tridentate ligand. 
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Oxovanadium moiety (V=O2) stretching, coupled with asymmetric C-C-O1e mode, 
appears in the spectrum of the complex, as a typical band at 987 cm-1. The bands 
assigned to the ethoxo group can be observed at expected frequencies and V-ligand 
modes are present in the predicted spectral region. 
 
3.4. Electronic spectroscopy 
The absorption spectra of the complex and the free ligand were recorded both in DMSO 
and in EtOH. Results indicate that no appreciable differences exist between the spectra of 
each compound in both solvents. Thus, only the spectra obtained in EtOH are presented, 
because the lower wavelength cut-off of that solvent allows the study of a wider spectral 
region. The spectra are shown in Figure 4, whereas experimental absorption maxima and 
calculated transition energies are listed in Table 4. Measurements in DMSO were useful to 
determine solutions stability, as the biological assays are carried out from stock solutions 
prepared in this solvent. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Electronic absorption spectra of complex (1) (solid line) and INHOVA (dotted 
line) in EtOH (1 x 10-5 M) in the 210-600 nm spectral range. 
 
In all cases, experimental bands are described by at least two one-electron excitations 
indicating that the complex under study is dominated by many-body effects. For simplicity, 
only the dominant transitions are used to assign the experimental bands. Dominant 
transitions are chosen according to their oscillator strengths. Calculated transitions 
describe very well the experimental bands as can be deduced from Table 4. 
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Table 4. Experimental absorption bands and calculated electronic transitions, in nm, for 
[VO(INHOVA) EtO(OH2)]+ in EtOH solution. Oscillator strengths, in atomic units, are also 
given. The proposed assignment based on calculations is provided. Percent contribution of 
one-electron excitations to the transitions and their assignment in terms of chemical 
species is given in parentheses. Only those calculated electronic transitions relevant for 
the assignments are listed. 
Exp. Calc. Osc. str. Assignment 
424 
429 0.2333 
HOMO – 1 → LUMO + 1 (44%, o-VA + INH → V) 
HOMO – 1 → LUMO (37%, o-VA + INH → INH + V) 
392 0.2386 
HOMO → LUMO + 3 (74%, o-VA → V) 
HOMO – 1 → LUMO (10%, o-VA + INH → INH + V) 
320 304 0.0706 
HOMO – 3 → LUMO + 1 (25%, EtO → V) 
HOMO – 4 → LUMO + 1 (25%, INH + EtO + V=O → V) 
HOMO – 1 → LUMO + 4 (17%, o-VA + INH → o-VA + INH + V) 
HOMO – 2 → LUMO (11%, o-VA + INH → INH + V) 
273 257 0.2297 
HOMO – 4 → LUMO + 2 (31%, INH + EtO + V=O → V=O) 
HOMO – 1 → LUMO + 6 (28%, o-VA + INH → V + EtO) 
HOMO → LUMO + 7 (25%, o-VA → V=O) 
234 
231 0.121 
HOMO – 7 → LUMO (69%, o-VA + INH → INH + V) 
HOMO – 3 → LUMO + 4 (11%, EtO → o-VA + INH + V) 
228 0.1047 
HOMO – 2 → LUMO + 4 (49%, o-VA + INH → o-VA + INH + V) 
HOMO – 3 → LUMO + 4 (14%, EtO → o-VA + INH + V) 
HOMO → LUMO + 8 (11%, o-VA → o-VA) 
222 0.1851 
HOMO – 7→ LUMO + 3 (28%, o-VA + INH → V) 
HOMO – 11 → LUMO (17%, o-VA + H2O → INH + V) 
HOMO – 10 → LUMO + 1 (15%, o-VA + V=O → V) 
HOMO – 8 → LUMO + 2 (14%, o-VA + INH → V=O) 
 
It can be seen from the proposed assignment that intraligand (IL) transitions within 
INHOVA are strongly coupled with ligand-to-metal charge transfer (CT) transitions. The 
experimental band observed at 424 nm is assigned to both IL and CT transitions. The 
band at 320 nm is found to be described by both IL and CT transitions with further 
contributions originated in transitions from the ethoxo and VO moieties to V. The 
experimental band at 273 nm exhibits mainly CT transitions from both INHOVA and ethoxo 
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to V and the VO group with some contribution of a transition from INHOVA to the ethoxo 
moiety. Finally, the band recorded at 234 nm is assigned mainly to IL and CT transitions. 
Comparison with free INHOVA electronic spectra (see Table 4 in ref. 25) shows that 
coordination to VO shifts absorption bands to higher wavelengths. HOMO and HOMO – 1 
are essentially the same both in INHOVA and in (1): they are located in the ligand with no 
contribution from V or VO, see Figure 5. However, the LUMO presents contribution from d 
atomic orbitals of V ion and, moreover, LUMO + 2 in free INHOVA becomes LUMO + 4 in 
the complex, also exhibiting contributions from d atomic orbitals of V ion (Figure 5). The 
contribution of d atomic orbitals of V to unoccupied MO stabilizes both LUMO and LUMO + 
4, thus leading to transitions with lower energies and, thus, higher wavelengths. With those 
arguments in mind, we notice that the bands at 222 and 304 nm in free INHOVA 
correspond to the calculated transitions found at 320 and 424 nm in the complex under 
study. The band at 336 nm in free INHOVA could be associated to a calculated transition at 
500 nm in the complex, with almost negligible oscillator strength of 0.03 atomic units. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Comparison of frontier orbitals of INHOVA and the complex under study involved 
in some electronic transitions that describe their electronic spectra. Note the presence of d 
orbitals of the V(V) ion in both LUMO and LUMO + 4 in the complex. 
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3.5. Electrochemical characterization of INHOVA and Complex (1) 
The redox behavior of the hydrazone ligand and the complex (1) are studied by cyclic 
voltammetry in DMSO and EtOH solutions. The compounds are stable in both solutions 
during the measurement time. However, in DMSO several adsorption processes modify 
the electrode surface leading to no reproducible voltammograms and erratic results. For 
this reason, only the results obtained for complex (1) in EtOH are considered and 
compared with those of the hydrazone ligand in the same experimental conditions. Cyclic 
voltammograms are obtained at several scan rates (v) and potential ranges to determine 
the nature of the individual processes. 
Figure 6 shows a representative cyclic voltammogram, at v = 0.1V/s, of each compound 
between +1.4V and -2.2V vs Ag/Ag+. As can be seen in the figure, the voltammogram of 
the ligand shows only one anodic current peak (A) at +0.69V. At a potential more positive 
than +1.0 V, decomposition current of the solvent occurs. When increasing scan rates 
(from 0.05 to 2V/s) are used to analyze the oxidation process, a positive shift of the anodic 
peak potential (Epa) is observed. On the return scan, at all scan rates investigated, no 
reduction current peak directly associated with this oxidation is observed. However, a 
small wave, which depends on the oxidation path, appears at -0.65V (data not shown). 
The electrochemical response is similar to the observed for the o-HVA precursor in DMSO 
[30]. It can be interpreted in terms of an oxidation charge transfer process followed by a 
fast chemical reaction [31]. Thus, according to the reported results, the anodic peak can be 
attributed to the oxidation of the -OH group of the o-HVA residue of the hydrazone ligand. 
After this oxidation path, a fast chemical reaction generates a new electrochemically active 
compound that is reduced, on the return scan, at the potential of the mentioned small 
wave [30]. This oxidation process (A) is absent in the cyclic voltammogram of the complex, 
where the OH group is deprotonated due to coordination to the metal center. 
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Figure 6. Comparative ciclic voltammograms of complex(1) (__) and INHOVA (---) at v = 
0.1 V s-1. Solution: EtOH/LiClO4. 
 
On the other hand, the voltammetric reduction of the ligand gives rise to three cathodic 
processes in the potential range between -0.8V and -2.2V. Moreover, at all scan rates 
analyzed, these peaks do not display any reverse signal on the subsequent anodic scan 
and the cathodic peak potentials (Epc) are shifted toward more negative values as the 
scan rate increases (data not shown). The first cathodic peak (B) in the voltammogram 
could be ascribed to the reduction of the -CH=N-NH- moiety [32]. This process probably 
leads to the cleavage of the single N-N bond with the consequent formation of new 
species, which are reduced at more negative potentials.  
The electrochemical behavior of complex (1) is studied in the same conditions as those 
discussed for the ligand. Fig. 6, illustrates a typical cyclic voltammogram of the vanadium 
complex where three main irreversible current peaks are evident. From the available 
electrochemical data it can be stated that, at the initial potential of +0.6V the electroactive 
species is the V(IV) complex. The small waves in the potential range between +0.2V and -
0.4V are due to adsorption/desorption processes on the electrode surface and are not 
discussed here. 
As can be seen from the Figure, complex (1) is reduced at more negative potentials than 
the free ligand. On the forward cathodic scan two well defined peaks at -1.75V and -2.0V 
are observed, without anodic counterpart at all scan rates analyzed. As v increases, these 
peaks shift toward more negative potential and no evidence of chemical reactions either 
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preceding or following the electrode process are observed (data not shown). Thus, it is 
possible to infer that both reductions are irreversible. For comparison with the behavior of 
the free ligand the first one could be ascribed to a ligand-centered process that probably 
involves the reduction of the –CH=N-N=CO coordinated moiety. Moreover, the metallic 
center is reduced to V(III) at -2.0V, whereas the anodic peak observed at +1.15V on the 
return scan can be assigned to the oxidation of the metal center to V(V). This last process 
is also evident when the potential sweep is first run in positive direction, showing that is 
independent of the reduction processes that occur at negative potentials. 
 
3.6. Cytotoxicity assays 
Both INHOVA and its oxidovanadium(V) complex showed cytotoxic activity in K562 cells, in 
a concentration-dependent manner. The activity presented by (1) is slightly higher than 
that of its ligand: concentrations required to inhibit 50% of cellular growth, the IC50 values, 
are 28.80 ± 3.48 µM and 36.46 ± 4.13 µM, respectively. These values are the mean of four 
independent determinations. The reference metallodrugs cisplatin and carboplatin show 
IC50 values of, respectively, 1.1 µM and 10.0 µM in the same experimental conditions [33]. 
However, due to the toxic side effects associated to platinum and to the emergence of 
resistant tumors, the search for new metal-based antitumor agents constitutes a field in 
continuous growth. Concerning V compounds, Meshkini and Yazdanparast described the 
chemosensitization of human leukemia K562 cells to taxol by a vanadyl salen complex. 
Besides, the complex itself was able to inhibit the proliferation of K562 cells. [34]. 
Lampronti and co-workers [35] studied the effects of a series of vanadium complexes on 
the growth of K562 cells. Authors conclude that the complexes in which vanadium 
presents a +5 oxidation state, along with their discrete anionic units, appear critical for the 
respective effects on those cells. In a recent review, Novotny and Kombian state that, in 
spite of the work published on the subject, our knowledge on the potential use of vanadium 
complexes as anticancer agents is to date lacking. In this sense, many preclinical, clinical 
and epidemiological studies are needed [36]. With the purpose of contribute to a better 
understanding of the antiproliferative activity of oxidovanadium(V) compounds and their 
related putative use in cancer therapy, and in view of the results presented here, we 
suggest both INHOVA and complex (1) as good candidates for further pharmacological 
investigations. 
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4. Conclusions 
A novel and stable ester-like complex, [VO(INHOVA) EtO(OH2)]Cl·H2O, was obtained from 
the interaction of oxovanadium chloride with the INHOVA hydrazone, the condensation 
product of isoniazid and o-vanillin.  
The crystal structure of the chloride salt of the cationic complex shows that INHOVA acts 
as a tridentate (O,N,O´) ligand and that it is present as a monoanion, due to the 
protonation of the pyridinic nitrogen. 
The distorted octahedral environment of the vanadium centre is completed with the oxo 
moiety, a disordered ethoxide group and a water molecule. The complex cations aggregate 
into a dimer by means of intermolecular H-bonds. The interaction with chlorides and 
crystallization water molecules stabilizes the bilayer overall arrangement. 
A detailed spectroscopic analysis has been performed. The FTIR spectrum of the solid 
shows the effect of coordination on the ligand vibrational modes and the appearance of 
vibrations involving the metal center were observed. Computational calculations based on 
DFT, including geometry optimization, were performed and employed to assist in the 
spectra interpretation. They predict a strong coupling among different modes and help in 
the assignment of the bands. 
Characterization in solution was carried out and data were also analyzed in comparison 
with the free ligand behavior. 
The electronic spectra show the changes in electronic distribution upon the complexation. 
Shifts in the intra-ligand transitions and the occurrence of charge transfer bands can be 
observed. Calculations were relevant in the spectra interpretation and denote that each 
absorption band can be described for more than one single-electron transition. 
As expected, cyclic voltametric measurements show that deprotonation and coordination 
to the metal center modify the redox behavior of INHOVA. Additionally, signals related to 
vanadium oxidation-reduction process appear in the cyclic voltammogram of the complex. 
Citotoxicity assays against the chronic myelogenous leukemia K562 cell line show that 
both (1) and INHOVA can be considered candidates for further investigations. 
 
Appendix A. Supplementary data 
CCDC 1551305 contains the supplementary crystallographic data for complex (1) 
(formula: C16 H19 N3 O6 V1 1+,H2 O1,Cl1 1-). These data can be obtained free of charge 
via http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge 
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Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-
336-033; or e-mail: deposit@ccdc.cam.ac.uk. 
A complete list of frequencies and respective assignments of IR spectra of INHOVA and 
complex (1) are provided as Supplementary Material (Table S1). 
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Graphycal Abstract 
A oxidovanadium(V) complex with a hydrazone ligand of isoniazid and o-vanillin was obtained. Its 
crystal structure was determined. It was fully characterized by means of spectroscopic and 
electrochemical methods. The assignments were accomplished with the help of theoretical 
calculations based on DFT methods. It showed cytotoxic activity in K562 cells. 
 
 
